enkephalin, ser(2), leu(5), thr(6)- has been researched along with staurosporine aglycone in 1 studies
Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (staurosporine aglycone) | Trials (staurosporine aglycone) | Recent Studies (post-2010) (staurosporine aglycone) |
---|---|---|---|---|---|
224 | 0 | 5 | 739 | 0 | 175 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, N; Misu, Y; Miyamae, T; Ueda, H | 1 |
1 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and staurosporine aglycone
Article | Year |
---|---|
Protein kinase inhibitor potentiates opioid delta-receptor currents in Xenopus oocytes.
Topics: Analgesics; Animals; Carbazoles; Chloride Channels; Enkephalin, Leucine; GTP-Binding Proteins; Indole Alkaloids; Mice; Oocytes; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Opioid, delta; RNA, Messenger; Signal Transduction; Xenopus laevis | 1994 |